Welcome to Blood Cancer United Newsroom
Get the latest news about how we are creating a world without blood cancers—and improving the quality of life of patients and their families.
Ways to Help
"Ways to Help" Article
Who We Are
"Who We Are" Article node
News
The Leukemia & Lymphoma Society’s 31st Annual Scenic Shore 150 Bike Tour Set to Ride the Shore for a Cure
The Leukemia & Lymphoma Society’s 31st Annual Scenic Shore 150 Bike Tour Set to Ride the Shore for a Cure
Research
Caribou Biosciences Reports Positive Clinical Data from Dose Escalation of CB-010 ANTLER Phase 1 Trial in r/r B-NHL
BERKELEY, Calif., July 13, 2023 - Caribou Biosciences, Inc. (Nasdaq: CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, …
News
When Philanthropy and Competition Go Hand-in-Hand: Leaders Nationwide are Helping Blood Cancer Patients Survive and Thrive
When Philanthropy and Competition Go Hand-in-Hand: Leaders Nationwide are Helping Blood Cancer Patients Survive and Thrive
News
The Leukemia & Lymphoma Society Makes Fast Company’s Fifth Annual List of the Best Workplaces for Innovators in Nonprofit Category
The Leukemia & Lymphoma Society Makes Fast Company’s Fifth Annual List of the Best Workplaces for Innovators in Nonprofit Category
Heath Ponder named as member of the National Philanthropy Committee
The Leukemia & Lymphoma Society (LLS) Georgia - South Carolina Region is pleased to announce the appointment of Heath Ponder, Director- Strategic Comm…
News
FDA Approves BiTE Therapy for Adults and Children with Leukemia Subtype
Blinatumomab has received full approval from the FDA after long-term data confirmed its safety and efficacy.
News
37 Patient Organizations Applaud Proposed Rule to Rein in Short-Term Health Plans
Short-term health plans don’t offer typical health insurance benefits and don’t include consumer protections such as coverage for pre-existing conditi…
For all media-related inquiries and interview requests please email
mediarelations@bloodcancerunited.org
A Blood Cancer United representative will respond as soon as possible.